Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation by Baez, María Verónica et al.
JCB: Article
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 195 No. 7  1141–1157
www.jcb.org/cgi/doi/10.1083/jcb.201108159 JCB 1141
M.V. Baez, L. Luchelli, and D. Maschi contributed equally to this paper.
Correspondence to Graciela Lidia Boccaccio: gboccaccio@leloir.org.ar
Dr. Colman died on 1 June 2011.
Abbreviations used in this paper: AHA, azidohomoalanine; AMPA, -amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPAR, AMPA receptor; Arc/
Arg3.1, activity-regulated cytoskeletal-associated protein; CaMKII, Ca
2+/CaM-
dependent  protein  kinase  II;  DCP1a,  decapping  enzyme  1a;  FMRP,  fragile   
X mental retardation protein; FUNCAT, fluorescent noncanonical amino acid 
tagging; GABA, -amino butyric acid; HPG, homopropargylglycine; IF, immuno-
fluorescence; NB, Neurobasal medium; NMDA, N-methyl-d-aspartic acid; NMDAR, 
NMDA receptor; PB, processing body; PI3K, phosphoinositide 3-kinase; RBP, RNA 
binding protein; SG, stress granule; SRE, Smaug recognition element; TTX, tetro-
dotoxin; UTR, untranslated region.
Introduction
Local translation at the synapse is an important mechanism   
for synaptic plasticity. Hundreds of mRNAs encoding signal­
ing molecules, channels, neurotransmitter receptors, and com­
ponents and regulators of the actin cytoskeleton, among other 
cellular functions, are selectively transported to distinct den­
dritic domains. There, their translation and stability is closely 
regulated upon stimulation by specific neurotransmitters or tro­
phic factors by several RNA binding proteins (RBPs) and micro­
RNAs. Deregulation of local translation compromises synapse 
formation and function, and provokes a plethora of neurologi­
cal disorders. The human condition fragile X mental retardation 
syndrome is a dramatic example (Steward et al., 1998; Wu et al., 
1998, 2005; Scheetz et al., 2000; Aakalu et al., 2001; Steward 
and Worley, 2001; Ostroff et al., 2002; Dubnau et al., 2003; 
Eom et al., 2003; Zalfa et al., 2003, 2006, 2007; Antar et al., 
2004; Atkins et al., 2004; Kelleher et al., 2004; Sutton et al., 
2004; Bagni and Greenough, 2005; Du and Richter, 2005; Fujii 
et al., 2005; Shiina et al., 2005, 2010; Ashraf et al., 2006; Goetze 
et al., 2006; Poon et al., 2006; Schratt et al., 2006; Sutton and 
Schuman, 2006; Vessey et al., 2006, 2008, 2010; Bramham and 
Wells, 2007; Giorgi et al., 2007; Muddashetty et al., 2007; 
Dictenberg et al., 2008; Costa­Mattioli et al., 2009; Fiore et al., 
2009; Holt and Bullock, 2009; Martin and Ephrussi, 2009; 
De Rubeis and Bagni, 2010; Dieterich et al., 2010; Hillebrand 
et al., 2010). Localized mRNAs are found in granules, collec­
tively known as neuronal RNA granules, that contain specific 
RBPs including Staufen 1 and 2, Pumilio, fragile X mental re­
tardation protein (FMRP), RNA granule protein 105 (RNG105), 
zipcode­binding protein 1 (ZBP1), survival of motor neuron 
M
ammalian Smaug1/Samd4A is a translational 
repressor. Here we show that Smaug1 forms 
mRNA-silencing foci located at postsynapses 
of hippocampal neurons. These structures, which we have 
named S-foci, are distinct from P-bodies, stress gran-
ules, or other neuronal RNA granules hitherto described, 
and are the first described mRNA-silencing foci specific 
to neurons. RNA binding was not required for aggre-
gation,  which  indicates  that  S-foci  formation  is  not  a 
consequence  of  mRNA  silencing.  N-methyl-d-aspartic 
acid (NMDA) receptor stimulation provoked a rapid and 
reversible  disassembly  of  S-foci,  transiently  releasing   
transcripts (the CaMKII mRNA among others) to allow 
their translation. Simultaneously, NMDA triggered global   
translational silencing, which suggests the specific activation 
of Smaug1-repressed transcripts. Smaug1 is expressed dur-
ing synaptogenesis, and Smaug1 knockdown affected 
the number and size of synapses, and also provoked an 
impaired response to repetitive depolarizing stimuli, as 
indicated by a reduced induction of Arc/Arg3.1. Our 
results suggest that S-foci control local translation, spe-
cifically responding to NMDA receptor stimulation and 
affecting synaptic plasticity.
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Forrest et al., 2004; Semotok et al., 2005; Johnson and Donaldson, 
2006; Oberstrass et al., 2006; Zaessinger et al., 2006; Tadros   
et al., 2007; Semotok et al., 2008; Foat and Stormo, 2009;   
Li et al., 2010; Ravindranathan et al., 2010). Here we found that 
Smaug1 forms granules in mature hippocampal neurons, which 
we have named S­foci, as they are apparently distinct from pre­
viously described neuronal RNA granules, as well as from PBs 
and SGs. S­foci are located at dendritic spines and behave as 
mRNA­silencing foci, being enhanced upon polysome break­
down, and disrupted upon polysome stabilization. We found 
that the Smaug1 RNA­binding domain is dispensable for S­foci 
formation, which indicates that Smaug1 aggregation is not the 
consequence of the binding to repressed mRNAs. Importantly, 
S­foci respond to synaptic stimulation, specifically to N­methyl­
d­aspartic acid (NMDA) receptor (NMDAR) activation, which 
provokes the dissolution of the S­foci and the release of tran­
scripts to allow their translation. We found that the messenger 
encoding the key molecule Ca
2+/CaM­dependent protein kinase 
II (CaMKII) is apparently regulated by this novel mechanism. 
Unlike most RBP components of neuronal granules, which are 
also present in nonneural cells, Smaug1 is neuron­specific and 
its expression is triggered during synaptogenesis. Remarkably, 
we found that Smaug1 knockdown provokes the formation   
of smaller and more numerous synapses. Moreover, Smaug1­ 
depleted neurons respond defectively to a repetitive depo­
larizing stimulus, as indicated by a reduced induction of activity­ 
regulated  cytoskeletal­associated  protein  (Arc/Arg3.1),  an 
activity marker gene. Our results suggest that Smaug1 regulates 
localized translation upon synaptic stimulation, thus affecting 
synapse biogenesis and/or stability.
Results
Smaug1 forms mRNA-silencing foci in 
cultured neurons
Having demonstrating the expression of Smaug1 in the cen­
tral nervous system (Baez and Boccaccio, 2005), we analyzed 
the distribution of mammalian Smaug1 in mature neurons by 
immunofluorescence (IF). We found that Smaug1 forms gran­
ules 0.5 µm in diameter, which were present in the cell body 
and dendrites (Fig. 1 A). Smaug1 granules were distinct from 
those containing FMRP, an RBP involved in mRNA regulation   
(Fig. 1 B; Bagni and Greenough, 2005; Dictenberg et al., 2008). 
As expected, primary fibroblasts and glial cells did not express 
Smaug1 (unpublished data; Baez and Boccaccio, 2005).
We have shown before that Smaug1 constructs transfected 
in nonneuronal cell lines form RNA granules that behave as   
silencing foci, as they are in dynamic equilibrium with translat­
ing polysomes (Baez and Boccaccio, 2005). We investigated 
whether neuronal Smaug1 foci behave similarly. We focused 
on dendritic granules, as the abundance of Smaug1 granules at 
the cell body precluded the analysis in this cell compartment. 
We found that a relatively long­exposure of cultured neurons 
to puromycin, a translation inhibitor that disrupts polysomes, 
enhanced the presence of Smaug1 granules, whereas cyclohexi­
mide, a drug that blocks elongation leading to ribosome stalling, 
provoked a moderate dissolution (Fig. 1 C). Shorter treatments 
(SMN), 4AIII, fused/translocated in sarcoma (FUS/TLS), and 
TAR DNA­binding protein 43 (TDP43), among others. Neu­
ronal RNA granules serve as the functional units for transport 
and translational control (Knowles et al., 1996; Köhrmann et al., 
1999; Steward and Worley, 2001; Kanai et al., 2004; Antar   
et al., 2004; Fujii et al., 2005; Shiina et al., 2005; Wu et al., 
2005; Barbee et al., 2006; Schratt et al., 2006; Vessey et al., 
2006; Giorgi et al., 2007; Bramham et al., 2008; Wang et al., 2008; 
Falley et al., 2009; Martin and Ephrussi, 2009; Thomas et al., 
2011). In addition to neuronal RNA granules, the somatoden­
dritic compartment contains processing bodies (PBs). PBs are 
ubiquitous mRNA­silencing foci, and they harbor untranslated 
mRNAs that can be released to allow translation. A plethora 
of PBs that differ subtly on composition are present in mam­
malian and insect neurons, and remarkably, neuronal PBs were   
recently shown to respond to synaptic stimulation (Barbee et al., 
2006; Cougot et al., 2008; Savas et al., 2008; Zeitelhofer et al., 
2008; di Penta et al., 2009; Miller et al., 2009; Thomas et al., 2011). 
Finally, stress granules (SGs), which are ubiquitous mRNA­ 
silencing foci specific to the stress response, transiently form in 
neurons exposed to a variety of noxious stimuli. Several RBPs 
present in neuronal RNA granules are recruited to SGs, where 
they regulate mRNA translation, aggregation, and molecular 
motor recruitment (Thomas et al., 2005, 2009; Shiina et al., 2005; 
Vessey et al., 2006; Didiot et al., 2009; Loschi et al., 2009; 
Bosco et al., 2010; Liu­Yesucevitz et al., 2010).
In this paper, we investigated the relevance of mammalian 
Smaug1/Samd4A, a posttranscriptional regulator that belongs 
to a novel family of RBPs (Aviv et al., 2003), in translational 
regulation  at  the  synapse.  Smaug  was  initially  described  in 
Drosophila melanogaster. In this organism, Smaug controls the 
stability and translation of hundreds of maternal mRNAs dur­
ing early development (Smibert et al., 1996; Dahanukar et al., 
1999; Smibert et al., 1999; Nelson et al., 2004; Semotok et al., 
2005, 2008; Tadros et al., 2007; Benoit et al., 2009). Drosophila 
Smaug mediates mRNA silencing by multiple mechanisms. One 
of them involves the recruitment of Cup, which binds eukaryote 
initiation factor 4E, thus interrupting its interaction with eukary­
ote initiation factor 4G and blocking translation initiation (Nelson 
et al., 2004). More recently, fly Smaug was shown to block cap­
dependent and independent translation by forming a highly   
stable repressed messenger RNP (Jeske et al., 2011). Drosophila 
Smaug is also able to trigger deadenylation by recruiting the 
CCR4–NOT  complex  and  specific  Piwi­interacting  RNAs 
(Zaessinger et al., 2006; Semotok et al., 2008; Rouget et al., 
2010). The yeast homologue Vts1 similarly triggers deadenyl­
ation of target mRNAs by recruiting the CCR4–NOT complex 
(Rendl et al., 2008). Two homologous genes, Smaug1/Samd4A 
and Smaug 2, are present in the mammalian genome. In a previ­
ous study, we reported that mammalian Smaug1 is present in the 
central nervous system and absent from nonneuronal cell lines 
(Baez  and  Boccaccio,  2005).  Mammalian  Smaug1  represses   
the translation of mRNAs carrying a specific motif termed 
Smaug recognition element (SRE), which mediates the bind­
ing  of  the  Drosophila  and  yeast  molecules  to  their  targets 
(Smibert et al., 1996; Dahanukar et al., 1999; Smibert et al., 1999; 
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had no effect (see Fig. 6). For comparison, the dynamics of neu­
ronal PBs identified by decapping enzyme 1a (DCP1a) staining 
were similarly analyzed. We found that PBs dissolved faster 
than  Smaug1  foci  upon  polysome  stabilization  (unpublished 
data). These observations are consistent with the behavior of 
PBs in nonneuronal cells (for reviews see Franks and Lykke­
Andersen, 2008; Anderson and Kedersha, 2009; Balagopal and 
Parker, 2009; Buchan and Parker, 2009; Kulkarni et al., 2010; 
Thomas et al., 2011). Thus, dendritic Smaug1 granules behave 
as mRNA­silencing foci, and are apparently less dynamic than 
PBs. We named structures that contain Smaug1; exclude FMRP, 
SMN, and Staufen 1 (Fig. 1; unpublished data); and are distinct 
from PBs and SGs (see the following section) “S­foci.”
Smaug1 foci are independent of PBs
We investigated the relationship between S­foci and SGs and 
PBs. Neuronal S­foci appeared distinct from SGs formed upon 
exposure of neurons to an oxidative stress stimulus, but they 
were frequently found in the vicinity of SGs, thus resembling 
the behavior of PBs (Fig. S1 A). In contrast, FMRP and Staufen 
were recruited to SGs, as described previously in neuronal and 
nonneuronal cells (Fig. S1 A; Thomas et al., 2005, 2009; Didiot 
et al., 2009; Martinez Tosar et al., 2011). We then analyzed 
the relationship between S­foci and PBs by visualizing DCP1a. 
We found that neuronal S­foci did not overlap with PBs identi­
fied by DCP1a. However, a significant proportion of the S­foci 
were detected in close contact with PBs (Fig. S1 B). Next, we 
investigated whether PBs are required for S­foci formation. We 
treated neurons with siRNAs against the PB components Hedls, 
Rck/p54, or 4ET, which are known to affect PB integrity in cell 
lines (Fenger­Grøn et al., 2005; Ferraiuolo et al., 2005; Thomas 
et al., 2009). We found that the numbers of DCP1a foci were re­
duced upon depletion of any of the above molecules (Fig. 2 A), 
as reported recently in Drosophila neurons upon depletion of 
Rck/p54/Me31B (Hillebrand et al., 2010). We simultaneously 
analyzed the presence of the S­foci and found that their num­
ber or size were not affected by any of the treatments against 
PBs (Fig. 2 A). Conversely, Smaug1 depletion did not signifi­
cantly affect the presence of PBs identified by DCP1a staining   
(Fig. S1 C). Collectively, these results indicate that PB integrity 
is not required for S­foci maintenance. However, the possibility 
that the S­foci were assembled before PB breakdown remained 
open. To investigate this, we used U2OS cells, which do not 
express  Smaug1  (Baez  and  Boccaccio,  2005).  As  expected, 
transfected Smaug1­ECFP form cytoplasmic granules in U2OS 
(Fig.  2,  A–C).  Overexpression  may  provoke  the  formation   
of unfolded protein aggregates, and we considered this possi­
bility. As described previously (Baez and Boccaccio, 2005), 
we found that Smaug1­ECFP foci are dynamic and behave as 
Figure 1.  Mammalian Smaug1 is expressed in neurons and forms mRNA-
silencing foci. Cultured hippocampal neurons were stained for the indi-
cated molecules. (A) Bars: (top) 5 µm; (bottom) 1 µm. (B) A magnification 
of an isolated dendrite is shown. Bar, 1 µm. (C) Hippocampal neurons 
were exposed to cycloheximide (CHX) or puromycin (PURO) during 3 h. 
The size and number of Smaug1 foci were measure in 100× confocal   
z-stack images and the area occupied by Smaug1 granules in 20 randomly 
selected dendrite fragments was calculated for each treatment. A moderate 
increase of Smaug1 granular signal was observed upon puromycin treat-
ment, whereas exposure to cycloheximide provokes a moderate reduction 
of Smaug1 granular signal. Error bars indicate standard deviation.
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obligate component of SGs, is not recruited to the Smaug1­
ECFP foci (Fig. S2 A). However, as described previously (Baez 
and Boccaccio, 2005), the SG component TIA1/TIAR is pres­
ent in a fraction of the larger Smaug1­ECFP foci (Fig. S2 A). 
This was restricted to the heterologous system, and TIA1/TIAR 
mRNA­silencing foci, thus discarding the possibility of abnormal 
protein aggregation. Transient overexpression of translational 
repressors may induce SGs (Wilczynska et al., 2005; Thomas 
et al., 2011), and therefore we investigated the relationship 
of Smaug1­ECFP foci with SGs. We found that eIF3, an 
Figure 2.  S-foci are independent of PBs. (A) Neurons were treated with the indicated siRNA, and the presence of S-foci and PBs visualized by DCP1a 
staining was analyzed in 20 randomly selected dendrite fragments (400 µm total length) for each treatment. Normalized values from two independent 
experiments are plotted. Representative IF images for the indicated molecules upon the distinct treatments are shown. Bottom, depletion of PBs visualized by 
RCK or Hedls relative to normal levels. In all cases, knockdown of Hedls or RCK provokes PB disruption without affecting the presence of S-foci. Error bars 
indicate standard deviation. (B) U2OS cells were transfected with Smaug1-ECFP and immunostained for the indicated PB markers. Close vicinity between 
S-foci and PBs is frequent (Fig. S2 A). The bottom row shows enlarged views of the boxed regions. (C) U2OS cells were treated with the indicated siRNAs, 
then transfected with the Smaug1-ECFP construct, and stained for DCP1a. Depletion of Hedls, Rck/p54, and 4ET was confirmed by Western blotting or 
RT-PCR (Fig. S2, B and C), and their effect on PB integrity was confirmed by IF (Fig. S2 D). Representative cells are depicted, and the percentage of the 
transfected cells with S-foci in each treatment is indicated. Similar results were observed in three independent experiments. The bottom row shows enlarged 
views of the boxed regions. (D) U2OS cells were transfected with the indicated constructs, and the proportion of the transfected cells with foci is indicated. 
One representative experiment out of five is shown. (E) U2OS cells expressing the indicated constructs were treated with cycloheximide (CHX), emetine 
(EME), puromycin (PURO), or hippuristanol (HIP) during 4 h, and stained for DCP1a. The proportion of cells with foci relative to that of untreated cells for 
each construct and the proportion of cells with PBs identified by DCP1a are plotted. S-foci and PBs disassembled upon polysome stabilization by cyclohexi-
mide or emetine, whereas SAM foci were fully resistant. Normalized values from 50 cells from a representative experiment out of three are shown. Error 
bars in E represents the standard deviation from triplicate coverslips. Bars: (A) 1 µm; (B–D) 10 µm.1145 Smaug1 mRNA-silencing foci at the synapse • Baez et al.
was never observed in neuronal S­foci. A significant propor­
tion of Smaug1­ECFP foci were in close contact, or virtually 
coincident with PBs visualized by DCP1a, Hedls, or RCK/p54   
(Figs. 2 B and S2 A). Then, we investigated the effect of PB 
breakdown. We first provoked PB disassembly by knockdown 
of Hedls, Rck/p54, or 4ET, as described previously (Fenger­Grøn 
et al., 2005; Ferraiuolo et al., 2005; Thomas et al., 2009), and 
then transfected Smaug1­ECFP.
The knockdown was confirmed by Western blot analy­
sis of Hedls and Rck/p54, and by RT­PCR for 4ET (Fig. S2,   
B and C). As expected, a strong reduction in the proportion of 
cells with PBs was observed upon treatment with the above 
siRNAs (Fig. S2 D). Then, we analyzed the presence of Smaug1­
ECFP foci. Strikingly, we found that between 40 to 47% of the 
transfected cells formed S­foci in all cases, which indicates that   
the PB components Hedls, Rck/p54, or 4E are not required for   
S­foci assembly in cell lines (Fig. 2 C).
It has been suggested that the assembly of mRNA­silencing   
foci is a consequence of silencing (Eulalio et al., 2007; Thomas 
et al., 2011). We analyzed whether a Smaug1 truncate termed 
SAM,  which  lacks  the  SAM  domain  that  mediates  RNA 
binding, was able to form foci (Fig. 2 D). As is the case for 
the full­length molecule, the SAM foci were distinct from 
SGs (Fig. S2 A). We found that the SAM domain is dispens­
able for foci formation, and consistent with this observation, 
the isolated SAM domain did not form foci (Fig. 2 D). We 
speculate that the SAM construct is not able to bind RNA, 
and thus we predict that SAM foci will not respond to poly­
some stabilization, a distinctive feature of mRNA­silencing foci. 
As expected, we found that SAM foci did not dissolve upon 
polysome stabilization by cycloheximide or emetine, whereas 
S­foci and PBs were significantly disassembled (Fig. 2 E), as 
described previously (Baez and Boccaccio, 2005). In spite of 
minor differences with neuronal S­foci, these observations in 
cell lines allowed us to conclude that S­foci formation is not 
the consequence of the binding to repressed mRNAs, and that 
neuron­specific factors are not required. In addition, S­foci for­
mation is independent of PBs.
Synaptic Smaug1 silencing foci respond to 
NMDAR activation
Regulated translation is known to occur at postsynaptic sites 
(Steward et al., 1998; Huang et al., 2002; Antar et al., 2004; 
Shiina et al., 2005; Schratt et al., 2006). Thus, we analyzed the 
presence of Smaug1 silencing foci at the synapse surroundings. 
To identify synapses, we immunostained the presynaptic marker 
synapsin and the postsynaptic molecule PSD95 in cultured   
hippocampal neurons. We found that between 55 and 75% of 
synapses contain S­foci (Fig. 3 A). S­foci were detected in 
close contact with PSD95 clusters (Fig. 3 A), which suggests 
an association with the postsynaptic density, a scaffold structure 
that holds neurotransmitter receptors. In addition, we found that 
Figure 3.  Smaug1 foci at the postsynapse. (A and B) Magnifications of 
isolated dendritic spines showing endogenous Smaug1 (A) or transfected 
Smaug1-ECFP (B), and the indicated markers. Endogenous or transfected 
Smaug1 form granules located at the postsynapse. (C) Smaug1 and FMRP 
were simultaneously stained in cultured neurons, and their presence in the 
synapses was evaluated. (D) Adult hippocampus slices were stained with 
the indicated antibodies. (D, top left) Tubulin III. (D, bottom left) A magni-
fication of the CA1 region, including cell bodies and dendrites is shown. 
PI, rabbit preimmune serum. (D, right) A representative magnification of 
the CA3 region showing four S-foci associated with a synapse. Enlarged 
views of the boxed regions are shown below. (E) Synaptoneurosomes (Sn) 
were isolated from adult hippocampus (Hipp) by sucrose gradient cen-
trifugation, then separated in a soluble extract (Sol) that was enriched in 
presynaptic components and that excluded PSD95, and a postsynaptic 
density-enriched fraction (PSD). Smaug1 is detected in the synaptoneurosomal 
and PSD fractions, and is absent from the soluble presynaptic fraction. Bars: 
(A and B) 1 µm; (D, left) 5 µm; (D, right) 1 µm.
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synapses  containing  S­foci  was  significantly  reduced  upon 
stimulation (Fig. 4 A). The response was rapid; it was detected 
1 min after depolarization, and 5 min after the stimulus the pro­
portion of synapses with S­foci was reduced to 50% relative to 
basal levels. In addition, the size of the remaining S­foci was 
significantly reduced. A prolonged treatment of 30 min did not 
further increase the response (Fig. 4 B). S­foci dissolution was 
reversible, and 16 h later the presence of S­foci at synapses was 
fully recovered (unpublished data). Remarkably, the effect 
was observed in the S­foci associated with the synapses, identi­
fied by PSD95 or synapsin staining, whereas the S­foci located 
in the dendritic shaft were not significantly altered, which sug­
gests that the dissolution of the S­foci involves a local response 
(Fig. 4, B and C).
We then investigated which synaptic receptors mediate   
S­foci dissolution. Most stimulatory hippocampal synapses re­
spond to glutamate, whereas inhibitory synapses in these cells   
respond to ­amino butyric acid (GABA). Next, we applied a 
short depolarizing stimulus in the presence of kynurenic acid, 
a blocker of the ionotropic glutamate receptors that respond to   
­amino­3­hydroxy­5­methyl­4­isoxazolepropionic acid (AMPA) 
or to NMDA. The effect of picrotoxin, a GABA­A receptor in­
hibitor, was also analyzed. We found that glutamate receptor 
blockage  completely  abrogated  the  dissolution  of  S­foci  trig­
gered by depolarization, whereas GABA­A receptor inhibition 
did not affect the response (Fig. 5 A).
Next, we investigated which glutamate receptor is involved. 
We used the NMDA antagonist 2­amino­5­phosphonopentanoate 
(APV) and the AMPA antagonist 6­cyano­7­nitroquinoxaline­2,3­
dione (CNQX). We found that NMDAR inhibition completely 
abrogated the response to depolarization, whereas AMPA re­
ceptor (AMPAR) inhibition had no effect on the dissolution of 
the S­foci triggered by KCl­mediated depolarization (Fig. 5 B). 
For comparison, we simultaneously analyzed the response of 
the FMRP granules. We found that FMRP granules responded 
to  AMPAR  activity,  in  agreement  with  a  previous  study   
(Antar et al., 2004). In addition, we found that in contrast to 
the S­foci, FMRP granules were not affected by NMDAR activ­
ity (Fig. 5 C).
To further assess the role of NMDAR in S­foci dynamics, 
we exposed hippocampal neurons to a short pulse of NMDA. 
Before stimulation, hippocampal cells were treated with tetro­
dotoxin (TTX), which blocks the opening of the voltage­gated 
Na
+ channel, thus leading to a depressed state. This treat­
ment did not affect the S­foci significantly. TTX­treated neu­
rons were stimulated over 5 min with 30 µM NMDA and 
allowed to recover. The number and size of the S­foci at syn­
apses were measured at several time points after the stimulus. 
In agreement with the above results, we found that the S­foci 
dissolved upon NMDAR activation. The effect was immediate 
and reversible. 5 min after NMDA exposure, the number of 
synapses containing S­foci was reduced to <50% relative to 
basal levels (Fig. 5 D), and the remaining foci were signifi­
cantly smaller (0.52 µm
2 in resting conditions vs. 0.37 µm
2 im­
mediately after the NMDA pulse). The effect lasted for 60 min 
after release of the stimulus, and cells started to recover within 
6 h afterward (Fig. 5 D).
Figure 4.  S-foci located at postsynaptic sites respond to depolarization. 
Hippocampal neurons were exposed to KCl as indicated in Materials and 
methods during the indicated time periods, and stained for the indicated 
proteins. (A) Representative dendrite fragments from control or depolar-
ized neurons are shown. Synaptic Smaug1 signal is reduced in depolar-
ized neurons. Bar, 1 µm. (B) The presence of S-foci in 600 synapses 
from 40 random-selected dendritic fragments, and the S-foci size from 100 
random selected S-foci was evaluated at the indicated time points. Nor-
malized values and standard deviation from duplicates are shown (error 
bars). (C) The number of S-foci in dendrite shafts after a 10-min KCl pulse 
was evaluated in triplicate experiments. The number of synapses remained 
constant through the analyzed time points (not depicted).
transfected Smaug1­ECFP similarly formed granules pres­
ent in the somatodendritic compartment and at postsynapses 
(Fig. 3 B). For comparison, we simultaneously investigated the 
presence of FMRP granules and found that most synapses con­
tained FMRP and/or Smaug1, and that their presence was not 
mutually exclusive (Fig. 3 C).
We also analyzed the presence of Smaug1 granules in   
hippocampal slices (Fig. 3 D). Cell bodies and dendrites were 
strongly labeled by the anti­Smaug1 serum. In addition, Smaug1 
granules frequently associated to synapsin clusters (Fig. 3 D). 
On average, 60% of synapsin patches contain one or two S­foci 
in their surroundings (Fig. 3 D, insets). Finally, we found that 
Smaug1 is present in hippocampal synaptosomes isolated by 
sucrose gradient centrifugation (Fig. 3 E). Moreover, Smaug1 
copurified with PSD95 in postsynaptic densities isolated from 
synaptosomes by extraction with Triton X­100 at pH 8.0 (Phillips 
et al., 2001). Smaug1 is absent from the soluble fraction ob­
tained by this procedure, which is enriched in presynaptic com­
ponents and excludes postsynaptic molecules (Fig. 3 E; Phillips 
et al., 2001).
Translation at the postsynapse is finely regulated by syn­
aptic stimulation, and we hypothesized that Smaug1­mediated 
repression is modulated by synaptic activity. We reasoned that 
if mRNA silencing by Smaug1 is released upon synaptic stimu­
lation, the number and/or size of the S­foci will decrease. Con­
versely, the presence of S­foci is expected to increase if synaptic 
stimulation enhances repression by Smaug1. Then, we exposed 
neurons to a short depolarizing stimulus by increasing potas­
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synapses containing S­foci and the foci size were significantly 
reduced. In striking contrast, puromycin or hippuristanol, which 
impair polysome assembly, completely abrogated the response 
triggered  by  depolarization  or  by  direct  NMDAR  activation   
(Fig. 6, A and B).
These results are compatible with the notion that S­foci 
dissolution upon NMDAR activation allows the release of si­
lenced mRNAs and their recruitment to polysomes. When poly­
some assembly is impaired, mRNAs would return to the S­foci, 
counteracting the dissolution triggered by synaptic stimulation.
We wondered whether S­foci plasticity involves Smaug1 
degradation during dissolution and de novo synthesis to allow   
reassembly. Against this possibility, we found that S­foci dissolu­
tion upon depolarization was not affected by the presence of   
the  proteasome  inhibitor  MG132  (unpublished  data).  In  addi­
tion, we followed S­foci dissolution and reassembly in the ab­
sence of protein synthesis, and found that the synthesis of new   
Smaug1 molecules is not required during aggregation (Fig. 6 C).   
As in Fig. 6 (A and B), polysome­stabilizing drugs did not im­
pair S­foci dissolution by NMDAR stimulation, and as expected 
(Fig. 5 D), S­foci remained disassembled for up to 1 h afterward 
(Fig. 6 C). S­foci recovery was enhanced in the presence of the 
translational inhibitor puromycin, which suggests that Smaug1 
molecules cycle between aggregated and disaggregated states to 
regulate the availability of specific transcripts.
Next, we investigated whether calcium influx is involved 
in the response. We treated the neurons with the intracellular 
calcium chelator EGTA­AM shortly before and also during the 
depolarization stimulus. We found that intracellular Ca deple­
tion abrogates S­foci dissolution, which indicates that calcium 
influx mediates the response (Fig. 5 E). Phosphoinositide 3­kinase 
(PI3K) and CaMKII are relevant kinases that are locally stimu­
lated by calcium influx upon NMDA activation. To investigate 
the participation of these signaling pathways, we used pharma­
cological inhibitors: wortmannin or LY294002 against PI3K, 
and KN­93 against CaMKII. We found that PI3K inhibition 
blocked  S­foci  dissolution  triggered  either  by  KCl­mediated 
depolarization (Fig. 5 E) or by NMDAR activation (Fig. 5 F).   
Inactivation of CaMKII had no effect (Fig. 5 F). Whether Smaug1 
is directly affected by PI3K remains to be investigated.
Smaug foci disassembly upon synaptic 
stimulation requires polysome assembly
We speculated that S­foci dissolution upon synaptic stimula­
tion is linked to mRNA release and translation activation. Thus, 
we analyzed the effect of translational blockers that enhance 
or impair polysome stability. We found that cycloheximide or 
emetine, which provoke polysome stalling, did not affect the 
dissolution of the S­foci triggered by either KCl or NMDA 
(Fig. 6, A and B; and not depicted). In all cases, the number of 
Figure 5.  S-foci respond to NMDAR activa-
tion.  (A–C)  Hippocampal  neurons  were  ex-
posed to KCl during 10 min in the presence 
or absence of the indicated drugs, and the 
number of synapses with associated Smaug1 
(A and B) or FMRP granules (C) was evalu-
ated.  KYNA,  kynurenic  acid;  PICRO,  picro-
toxin. (D) Neurons were pulsed with NMDA 
as  indicated  in  Materials  and  methods  and 
allowed to recover, and the presence of S-foci 
at the synapses was analyzed. S-foci size nor-
malized to control values at each time point 
is indicated. Similar results were observed in 
three independent experiments including dif-
ferent time points. (D, bottom) Representative 
IF images corresponding to the experiments 
depicted. Bar, 1 µm. (E and F) Neurons were 
exposed to KCl or NMDA in the presence of 
the indicated drugs, and the presence of S-foci 
associated to synapses was evaluated as in 
Fig. 4 B. E-AM, EGTA-AM; W, wortmannin; 
KN,  KN93;  LY,  LY294002.  Approximately 
100  dendritic  fragments  from  20  neurons 
were analyzed for each data point. Error bars 
indicate  standard  deviation  from  triplicate 
coverslips in a representative experiment.JCB • VOLUME 195 • NUMBER 7 • 2011   1148
NMDA induces the dissociation of Smaug1 
from CaMKII mRNA granules
CaMKII  mRNA  is  known  to  be  locally  translated  upon 
NMDA stimulation (Huang et al., 2002; Banerjee et al., 2009), 
and thus we sought to investigate whether the S­foci are in­
volved in the regulation of this messenger. First, we analyzed 
whether Smaug1 and CaMKII mRNA colocalize. We per­
formed FISH analysis and found that, as reported before, 
this transcript is present in granules in the soma and dendrites. 
Simultaneous staining of Smaug1 revealed that a significant 
proportion of CaMKII mRNA granules are associated with 
S­foci (Fig. 7 A). Both in the dendritic shaft and at the synapse 
surroundings, 45% of CaMKII mRNA granules associated   
with S­foci at a distance <150 nm (averaged from three in­
dependent stainings), which is compatible with a intermolecular   
interaction, as described for other RBPs and their target mRNAs 
(Giorgi et al., 2007).
Next, we investigated whether this association is affected 
by NMDAR stimulation. After a 5­min NMDA pulse, neurons 
were stained for CaMKII mRNA, Smaug1, and synapsin. As 
before (Figs. 5 D and 6 B), NMDA exposure provoked the dis­
solution of the synaptic S­foci, which were reduced from 50 ± 3% 
to 32 ± 2% (Fig. 7 B). In addition, we found that the presence of 
CaMKII mRNA granules at the synapse was enhanced by 
NMDAR stimulation, thus paralleling the recruitment of this 
messenger upon stimulation of metabotropic receptors (Kao et al., 
2010). The proportion of synapses with CaMKII mRNA gran­
ules increased from 33 ± 3% to 43 ± 3% (Fig. 7 B). Importantly, 
in spite of this increase on the number of synapses with CaMKII 
mRNA, the number of synapses where CaMKII mRNA colo­
calized with S­foci was reduced to half the normal values. In 
resting conditions, 16 ± 2% of the synapses contain CaMKII 
mRNA  granules  that  colocalize  with  S­foci,  and  this  value 
dropped to 8 ± 1% upon the NMDA pulse (Fig. 7 B). Overall, co­
localization at the synapse was reduced from 50 ± 3% to 18 ± 3% 
upon NMDA exposure (Fig. 7 B). The effect was not restricted 
to the synapses, and in the dendritic shaft the colocalization be­
tween CaMKII mRNA granules and S­foci dropped from 45 ± 5% 
to 30 ± 2%. Whether CaMKII mRNA molecules free of Smaug1   
represent translating mRNA molecules remains to be investi­
gated. Supporting this possibility, it was recently shown that 
CaMKII mRNA in dendrites is mostly found as a single mole­
cule, and thus, we speculate that either repressed or polysome­
engaged CaMKII mRNA may render similar discrete stainings. 
Finally, as expected, we found that CaMKII levels increased 
Figure 6.  S-foci dissolution upon synaptic stimulation requires polysome 
assembly. (A–C) Hippocampal neurons were exposed to KCl or NMDA 
as indicated in Materials and methods, in the presence or absence of the 
indicated translation inhibitors. CHX, cycloheximide; PURO, puromycin; 
Hip, hippuristanol. (A and B) The proportion of synapses containing S-foci 
relative to basal levels from three independent experiments is plotted, and 
IF images of representative dendritic fragments for the indicated treatments 
are depicted. Bars, 1 µm. (C) TTX-silenced hippocampal cells were stimu-
lated with NMDA in the presence or absence of cycloheximide or emetine 
(EME), which stall polysomes, and allowed to recover during 60 min, in 
the presence or absence of puromycin, which disrupts polysomes. S-foci 
were analyzed as in Figs. 4 and 5. The continuous inhibition of protein 
synthesis does not affect S-foci reassembly. Similar results were obtained 
in a duplicate experiment. Approximately 50 dendritic fragments (total 
length, 750 µm) from 20 neurons were analyzed for each data point. Error 
bars indicate standard deviation.
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by translation inhibitors. We found that cycloheximide com­
pletely abrogates the signal in both cell soma and dendrites of 
both AHA and HPG, which were incorporated linearly dur­
ing at least 1 h (Fig. 8, A and B; and not depicted). Then we 
performed a sequential metabolic labeling to asses the effect 
of NMDA in local translation at dendrites. We found that a 
short treatment with NMDA significantly blocked the incor­
poration of labeled amino acids (Fig. 8, B and C). The effect 
was immediate, and three independent experiments showed a 
reduction of protein synthesis to 42–54% relative to nonstimu­
lated neurons during the first 30 min (Fig. 8, B and C; and 
not depicted). Local translation slowly recovered, but it was 
still significantly lower 60 min after the stimulus. All these 
observations suggest that local NMDAR activation provokes a 
global translational silencing, and at the same time allows the 
translation of CaMKII mRNA and other unknown mRNAs 
by triggering S­foci dissolution.
locally after NMDA stimulation, as judged by IF analysis with 
a specific antibody (Fig. 7 C).
Then,  we  investigated  whether  S­foci  dissolution  by 
NMDA correlates with a global stimulation of local translation. 
We used the recently developed fluorescent noncanonical amino 
acid tagging (FUNCAT) strategy, which was successfully 
used to demonstrate changes in local translation in dendrites 
upon exposure to brain­derived neurotrophic factor (BDNF; 
Dieterich et al., 2010). In brief, neurons were pulsed with the 
methionine  surrogate  azidohomoalanine  (AHA)  to  evaluate 
basal synthesis, then exposed to NMDA and incubated for 
variable time periods with a second methionine substitute, 
homopropargylglycine  (HPG;  see  Materials  and  methods). 
Then, incorporated AHA and HPG were covalently tagged with 
specific fluorescent molecules, and signal intensities were de­
termined by confocal microscopy. First, we assessed whether 
incorporation of these noncanonical amino acids was blocked 
Figure  7.  CaMKII  mRNA  associates  to  S-foci  in  an 
activity-dependent  manner.  (A)  CaMKII  mRNA  and 
Smaug1 were simultaneously detected by FISH and IF, 
respectively. Between 40 and 60% of CaMKII mRNA 
granules colocalize or are in close contact with S-foci. A 
representative dendrite is shown. (B) Neurons were stimu-
lated with NMDA during 5 min and stained for CaMKII 
mRNA, Smaug1, and synapsin. The number of CaMKII 
mRNA granules at the synapse, associated to S-foci (S+) 
or not (S), and the number of synaptic S-foci, associ-
ated to CaMKII granules or not, are plotted. Approxi-
mately 300 synapses from 20 random selected neurons 
were analyzed in each case. Error bars indicate standard 
deviation. (B, bottom) Representative immunofluorescent 
images of synaptic S-foci and CaMKII mRNA granules 
either colocalizing or not colocalizing for each condition. 
The percentage relative to the total number of synapses 
and standard error is indicated in each case. (C) Neurons 
were stimulated with NMDA during 5 min and immuno-
stained for CaMKII 30 min after the pulse. Representa-
tive dendritic fragments showing an increase of CaMKII 
signal at the dendritic spine are depicted. Bars: (A, left) 
10 µm; (A, right) 1 µm; (B) 1 µm; (C) 2 µm.JCB • VOLUME 195 • NUMBER 7 • 2011   1150
accumulate simultaneously with synapsin and PSD95 after the 
eighth day in culture (Fig. 9 A). In contrast, as expected, we 
found that FMRP and Staufen1 were constitutively expressed 
(unpublished data). Thus, Smaug1 expression coincides with 
synaptogenesis in cultured hippocampal neurons.
To investigate the role of Smaug1 in synaptogenesis, we 
treated hippocampal cells at the sixth day in culture with a pool 
of siRNAs against Smaug1 (siSmaug1). RT­PCR analysis per­
formed after 15 d in culture indicated that Smaug1 mRNA   
levels were reduced to 10% relative to control levels. Efficient 
depletion of the protein was confirmed by Western blotting and 
Smaug1 affects synapse formation
Translational regulation at the synapse is important for synapse 
remodeling and stabilization. Having demonstrated that Smaug1 
forms mRNA­silencing foci that respond to synaptic stimula­
tion, apparently regulating the key transcript encoding CaMKII, 
among others, we then investigated whether Smaug1 affects 
synapse formation or function. First, we investigated the ex­
pression of this protein during neuron development in vitro by 
Western blot analysis of Smaug1 and selected synapse compo­
nents (Fig. 9 A). We found that Smaug1 expression was negli­
gible during the first week, and that this molecule began to 
Figure  8.  NMDAR  activation  inhibits  global  translation  at  the  dendrite.  The  FUNCAT  strategy  was  used  as  indicated  in  Materials  and  methods.   
(A) Cultured neurons were pulsed with HPG or AHA in the presence or absence of cycloheximide (CHX), and the incorporated modified amino acids were 
covalently coupled to Alexa Fluor 488 or 595. Translation inhibition completely abrogated the signal. Insets show representative dendrite fragments. Bars: 
(left) 20 µm; (right) 1 µm. (B) HPG and AHA were used sequentially to evaluate the protein synthesis rate before and after the stimulus, respectively. HPG 
and AHA signal intensities were measured in 40 dendrite fragments (total length, 800 µm) for each time point. AHA incorporation at different times after 
stimulation relative to basal HPG incorporation is plotted. One representative experiment out of four is depicted; error bars indicate the standard deviation 
from triplicate coverslips. (C) Representative dendrite fragments showing the NMDA inhibitory effect on protein synthesis in dendrite shafts and spines. 
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IF analysis (Figs. 9 B and S1 C). Strikingly, an alteration in 
synapse puncta was observed in siSmaug1­treated cells. We 
found that both PSD95 and synapsin clusters were smaller and 
more numerous than in control or siNT­treated cells (Fig. 9 C 
and not depicted). A quantitation of these parameters in five in­
dependent experiments indicated that Smaug1 knockdown re­
duced synapse size to 65% of normal values, and provoked a 
duplication or triplication of their number (Fig. 9, D and E). To 
rule out off­target effects, the four RNAi sequences present in the 
siSmaug1 pool were analyzed separately. We found that two of 
them provoked an alteration in synapse number and size com­
parable to the effect of the pool (Fig. 9, C and D); all this indi­
cates that the effect is specific to Smaug1 knockdown.
PSD95­containing  synapses  in  hippocampal  cells  are 
mostly excitatory, and are located in dendritic spines. To visual­
ize dendritic spines, neurons were transfected with ECFP and 
stained for PSD95 (Fig. 9 F). As expected, PSD95 clusters were 
located at the tip of dendritic spines. Remarkably, dendritic 
spines were longer and thinner in siSmaug1­treated cells, thus 
resembling an immature morphology.
Finally, we wondered whether this morphological altera­
tion impaired synapse excitability. To investigate this, we ex­
posed hippocampal neurons to a repeated depolarizing stimuli, 
which simulates a long­term potentiation (LTP)­like response 
(Wu et al., 2001), and stained the cells for the early activity­
related marker Arc/Arg3.1 (Steward et al., 1998; Steward and 
Worley, 2001). As expected, we found that Arc/Arg3.1 was 
rapidly induced in control or siNT­treated neurons (Fig. 10,   
A and B). In these cells, the Arc/Arg3.1 signal intensity doubled 
at 60 min after stimulation. In striking contrast, Arc/Arg3.1 ex­
pression was virtually not induced in siSmaug1­treated neurons 
(Fig. 10 B). Altogether these observations indicate that Smaug1 
knockdown alters synapse size and number, and concomitantly 
provokes a defective synaptic response.
Discussion
In this paper, we describe for the first time the existence of a 
novel kind of mRNA­silencing foci specific to neurons. These 
silencing  foci,  which  we  named  S-foci,  contain  mammalian 
Smaug1/Samd4A, an RNA­binding protein that belongs to a 
novel family of posttranscriptional regulators. S­foci are dis­
tinct from PBs and SGs, and from other neuronal RNA gran­
ules hitherto described (for reviews see Kiebler and Bassell, 
2006; Anderson and Kedersha, 2009; Buchan and Parker, 2009; 
Figure  9.  Smaug1  knockdown  affects  synapse  size  and  number.  
(A) Western blot of postnuclear protein extracts (10 or 5 µg) from cultured 
hippocampal neurons at 1, 8, 15, or 23 d in vitro with the indicated anti-
bodies. (B–F) Neurons were treated with the indicated siRNAs as described 
in Materials and methods. (B) Smaug1, Map2, and tubulin III levels were 
evaluated by Western blotting. Signal intensity relative to that of -actin 
is indicated. An siRNA against Smaug 2 had no effect on Smaug1 levels 
(not depicted). (C) Representative dendrite fragments stained with the 
indicated synapse or cytoskeleton markers are shown. (D and E) The size 
and number of synaptic puncta identified by simultaneous or independent 
staining of PSD95 and synapsin was measure as indicated in Materials 
and methods. (D) Summary of the normalized synapse size and number 
relative to that of siNT-treated neurons in three independent experiments 
with the siSmaug1 pool, and in a representative experiment comparing 
the four different siRNA. (E) Synapse size distribution in a representative 
experiment with the siSmaug1 pool. Random selected dendritic fragments 
from 10 neurons (total length, 5,000 µm) were analyzed in each case.   
(F) Neurons were transfected with ECFP and treated with the indicated 
siRNAs as indicated in Materials and methods. Representative dendrite 
fragments stained for ECFP and synapsin are shown. Dendritic spines were 
more numerous upon Smaug1 depletion. Bars, 2 µm.
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Martin and Ephrussi, 2009; Thomas et al., 2011). Like PBs, the 
S­foci behave as mRNA­silencing foci, as they are able to re­
lease  transcripts  allowing  their  incorporation  to  polysomes. 
Relevantly, S­foci dynamics depend greatly on neuron activity, 
and  our  observations  suggest  that  the  CaMKII  mRNA,  and 
likely other unknown transcripts, cycle between S­foci and 
polysomes in an activity­dependent manner, thus paralleling the 
cycling  of  specific  mRNAs  between  PBs  and  polysomes  in 
other cellular contexts. We speculate that similar foci exist in 
Drosophila peripheral neurons, where dSmaug regulates spe­
cific  mRNAs  (Brechbiel  and  Gavis,  2008).  Supporting  this   
assumption, Drosophila Smaug is found in foci in fly embryos 
and forms granules when expressed in cell lines (Baez and 
Boccaccio, 2005; Zaessinger et al., 2006; Rouget et al., 2010).
The molecular mechanism for mRNA repression by mam­
malian  Smaug1  is  unknown.  Drosophila  Smaug  acts  by  two 
pathways: it represses translation by blocking initiation at the 
level of 4E–4G interaction and by capturing target transcripts in 
repressed RNP complexes (Jeske et al., 2011). In addition, Dro-
sophila Smaug initiates mRNA decay by triggering deadenyl­
ation (Nelson, et al., 2004; Zaessinger, et al., 2006; Tadros, et al., 
2007; Rendl et al., 2008; Rouget, et al., 2010). Paralleling the 
functions of the Drosophila molecule, mammalian Smaug1 may 
block initiation, may mediate deadenylation, which is frequent in 
neuronal mRNAs (Du and Richter, 2005), or may govern the for­
mation of masking RNPs where mRNAs are sequestered from 
translation factors. All these mechanisms are compatible with the 
formation of Smaug1 mRNA­silencing foci. Whether Smaug1 
aggregation in discrete structures is required for efficient mRNA 
repression is unknown. Several proteins involved in mRNA 
silencing have distinct oligomerization domains (Franks and 
Lykke­Andersen, 2008; Salazar et al., 2010; Thomas et al., 2011), 
and how aggregation contributes to mRNA repression is a matter 
of debate. Nevertheless, our finding that S­foci formation does 
not require binding to RNA indicates that aggregation is not a 
consequence of mRNA silencing, and supports the hypothesis 
that the formation of oligomeric structures is important for 
Smaug1 function. Transcripts located at the synapses are trans­
ported relatively long distances from the cell body, and this trans­
port is performed in granules (Knowles et al., 1996; Köhrmann   
et al., 1999; Steward and Worley, 2001; Kanai et al., 2004; Falley 
et al., 2009; Martin and Ephrussi, 2009). Thus, besides putatively 
enhancing translational repression by physical sequestration of 
mRNAs, the self­aggregation of a translational regulator may 
contribute to the assembly of transport­competent complexes 
carrying repressed mRNAs. Conversely, dissolution of S­foci 
upon synaptic stimulation may contribute to restrict the move­
ment of transcripts that are required at the synapse. The molecu­
lar mechanism underlying S­foci aggregation is unknown, and is 
likely to involve oligomerization domains and motor molecules, 
which govern the assembly of mRNA­silencing foci in general 
(Franks and Lykke­Andersen, 2008; Loschi et al., 2009; Salazar 
et al., 2010).
We found that mammalian S­foci associate to synapses 
and selectively respond to NMDAR activation, dissolving and 
facilitating  the  translational  activation  of  CaMKII  mRNA 
and a plethora of unknown transcripts. The response is im­
mediate and transient, and involves calcium influx and PI3K 
signaling (see the hypothetical model in Fig. 10 C). Whether 
Smaug1 oligomerization is directly controlled by this signaling 
Figure 10.  Smaug1 knockdown affects neuron excit-
ability. Neurons were treated with the indicated siRNA 
and  exposed  to  a  repeated  depolarizing  stimulus.   
(A) Arc/Arg3.1 was detected by IF at the indicated times 
and shown in glow scale. Bar, 20 µm. (B) Integrated 
intensity in the cell bodies from 100 neurons from dupli-
cate coverslips was quantified in 20× micrographs. A 
duplicate experiment with similar results was performed. 
(C) Hypothetical model for a role of Smaug1 in local 
translation at the synapse and its regulation by NMDA. 
CaMKII mRNA and other repressed transcripts would 
be associated with the S-foci, likely as single molecules 
(see Discussion; Mikl et al., 2011). Upon NMDAR stimu-
lation, the S-foci dissolve, likely facilitating the transla-
tion of selected mRNA. Simultaneously, local translation 
is globally repressed. Local translation of CaMKII is 
known  to  mediate  synapse  strength,  and  additional 
unknown  transcripts  regulated  by  Smaug1  may  also 
contribute. (D) Putative SREs are present in the 3 UTR 
of CaMKII mRNAs from distinct species. In addition, 
conserved putative SREs are present at the coding re-
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hippocampi were dissected from Sprague Dawley rats at embryonic day 18 
and digested with trypsin. Cells were seeded on poly-d-lysine (Sigma-
Aldrich)-coated glass coverslips. Cultures were maintained in Neurobasal 
medium (NB; Invitrogen) supplemented with B27 (Invitrogen) and gluta-
mine (complete NB; Invitrogen) at 5% CO2. Cell lines were transfected with 
either Lipofectamine 2000 Transfection Reagent (Invitrogen) or Jet Prime 
(Polyplus Transfection) according to manufacturer’s instructions. Neurons 
were transfected one day after plating using Lipofectamine 2000 Transfec-
tion Reagent (Invitrogen) during 4 h, and analyzed at day 15. The follow-
ing constructs were used: (a) A full-length Smaug1 fused to either EGFP 
or V5 (Baez and Boccaccio, 2005). (b) ECFP-SAM, including two frag-
ments of hSmaug1: amino acids 1–317 fused to amino acids 376–717 
and tagged with ECFP in the N terminus. An hSmaug1 fragment spanning 
amino acids 1–376 was PCR-amplified from the pCDNA6–V5–hSmaug1 
described previously (Baez and Boccaccio, 2005) using 5-TAATACGACT-
CACTATAGGG-3 and 5-AAGGCGAGCCTCGAGGGTG-3 as primers, 
digested with HindIII and XhoI, and inserted between the HindIII and SalI 
sites of pECFP-C3 (Takara Bio Inc.). A second amplification was performed   
with 5-GCGAGCCTCGGGTGTGTTACGAGC-3 and 5-CATGGTCCTGC-
TGGAGTTCGTG-3 as primers. The hSmaug1 N-terminus hSmaug1 including 
amino acids 376–717 was amplified using 5-GCTCGTAACACACCCGA-
GGCTCGC-3 and 5-CGTCGCCGTCCAGCTCGACCAG-3 as primers. The 
last two PCR products contained a 12-bp overlapping region, and were 
fused by splicing with overlapping extension PCR (SOE-PCR), using the 
primers  5-CGTCGCCGTCCAGCTCGACCAG-3  and  5-CATGGTCCT-
GCTGGAGTTCGTG-3. This PCR product was digested with HindIII and 
BamHI and inserted between the HindIII and BamHI site of the pECFP-N1 
plasmid (Takara Bio Inc.). (c) ECFP-SAM: The region encoding the RBD 
was PCR-amplified from a hSmaug1-ECFP construction (Baez and Boccac-
cio, 2005) using the primers 5-CCGCTGCTCGGAATTCATTCCA-3 and 
5-AAGGCGAGCCTCGAGGGTG-3,  digested  with  EcoRI  and  XhoI, 
and inserted between the EcoRI and SalI sites of the pECFP-C1 plasmid 
(Takara Bio Inc.).
siRNA treatment
U2OS cells were treated with a nontargeting siRNA (siNT) 5-UAGCGA-
CUAAACACAUCAA-3; an siRNA anti-Hedls (siHedls, catalog no. 004397; 
Thermo Fisher Scientific); anti-Rck/p54 (siRck/p54, catalog no. 0143295); 
or an siRNA against 4ET (5-GAACAAGAUUAUCGACCUA-3; Ferraiuolo 
et al., 2005) used at 50 nM, and transfected 72 h afterward with the indi-
cated plasmids. Jet Prime was used for both steps. Hippocampal neurons 
were allowed to grow for 6 d in vitro, incubated with 100 nM siRNA 
(Thermo Fisher Scientific) complexed with Lipofectamine 2000 Transfection 
Reagent (Invitrogen) for 4 h, and analyzed at 15 d in vitro unless otherwise 
indicated. Either a pool against rat Smaug1 (catalog no. M-086491-00-
0010)  containing  the  sequences  5-AAUAUAAGCUCCUAUCUAC-3 
(siSmaug1a), 5-GACCGGACCUCCACAAUCU-3 (siSmaug1b), 5-UGGCA-
GAACUCUCGGGAUU-3 (siSmaug1c), and 5-ACGCGAAAGUAGAGU-
AUAU-3 (siSmaug1d) at 25 nM each or the individual sequences at 100 nM 
were used. A pool of four sequences against rat Smaug2 (siSmaug2, cata-
log no. M-081919-00) and an siCONTROL nontargeting pool (D-001810-10;   
Thermo Fisher Scientific) were used at 100 nM.
Drug treatment and neuron stimulation
In all cases, stock solutions were diluted into conditioned medium. Sodium 
arsenite, used at 1 mM cycloheximide, and puromycin, used at 250 µg/ml, 
were obtained from Sigma-Aldrich. Emetine, used at 1 µg/ml, was a gift 
from I.D. Algranatti (Fundación Instituto Leloir, Buenos Aires, Argentina). 
Hippuristanol was provided by J. Pelletier (McGill University, Montreal, 
Quebec, Canada) and used at 0.01 mg/ml. Neuron depolarization was 
induced in 17–20-d cultures by increasing KCl (Sigma-Aldrich) concen-
tration up to 55 mM during 10 min unless otherwise indicated. When 
indicated, depolarization was performed in the presence of kynurenic 
acid, used at 4 mM, picrotoxin, AP5, or CNQX (provided by A. Schinder, 
Fundación Instituto Leloir; and O. Uchitel, University of Buenos Aires, 
Buenos Aires, Argentina), all used at 50 µM and added 5 min before 
stimulation. For NMDAR stimulation, 1 µM TTX (Tocris Bioscience) was 
applied overnight, followed by a five min-pulse with 30 µM NMDA 
(Sigma-Aldrich) and a variable recovery period in NB. Wortmannin and 
EGTA-AM (Sigma-Aldrich), used at 20 µM, were added five min before 
neuron stimulation. KN93, used at 2 µM, and LY294002, used 10 µM, 
were from Sigma-Aldrich. Stimulation by repeated depolarization was 
induced as described previously (Wu et al., 2001). In brief, primary hippo-
campal neurons at 24 d in vitro were treated with 1 µM TTX for 1 d to 
block spontaneous activity. Then, repeated depolarization stimuli with 
pathway remains to be investigated. We found that AMPAR 
or GABAR activity do not affect S­foci dynamics. In contrast, 
FMRP granules respond to AMPAR stimulation (this paper and 
Antar et al., 2004), which indicates that distinct neuronal gran­
ules specifically respond to distinct stimuli. Further supporting   
a remarkable specificity of the response, we found that while 
Smaug1­mediated  repression  is  released,  NMDAR  stimula­
tion globally inhibits local protein synthesis, in agreement with 
previous studies (Leski and Steward, 1996; Marin et al., 1997; 
Scheetz et al., 2000; Sutton et al., 2004, 2006, 2007; Schuman 
et al., 2006).
The  messenger  encoding  CaMKII  is  activated  by 
NMDAR stimulation via several mechanisms, including cyto­
plasmic polyadenylation and relief from microRNA silencing 
(Scheetz et al., 2000; Steward and Worley, 2001; Huang et al., 
2002; Ashraf et al., 2006; Bramham et al., 2008), all compatible 
with the Smaug1­mediated repression suggested here. Human 
Smaug1  recognizes  the  SRE  motifs  from  the  Drosophila  
nanos mRNA (Baez and Boccaccio, 2005), and thus we specu­
late that the transcripts regulated by mammalian Smaug1 will 
contain related motifs. A putative SRE is present in the 3 un­
translated region (UTR) of the human, rat, and mouse CaMKII   
(Fig. 10 D). The relevance of these elements in the regulation of 
CaMKII mRNA by Smaug1 remains to be investigated. It is 
well established that CaMKII affects spine size and synaptic 
function (Pi et al., 2010), and thus, we speculate that dysregula­
tion of this messenger contributes to the serious synaptic defect 
provoked by Smaug1 depletion.
Smaug1 is expressed late during neuronal differentiation, 
coincident with the expression of key synaptic components 
and with the appearance of visible synaptic contacts. Several 
mRNAs relevant to synapse function start to accumulate at this 
developmental time (Paradis et al., 2007), and thus Smaug1 may 
have a role in the local control of these new mRNAs. In ad­
dition to its contribution to the regulation of local translation 
by synaptic stimulation, we speculate that Smaug1 helps the 
profound remodeling of the transcriptome that occurs during   
synaptogenesis (Paradis et al., 2007). We speculate that, par­
alleling the role of Drosophila Smaug during the maternal­ 
to­zygotic transition, during which fly Smaug down­regulates 
hundreds of maternal mRNAs (Tadros et al., 2007; Benoit et al., 
2009), mammalian Smaug1 may be involved in a massive si­
lencing of early mRNAs that are not required after synapto­
genesis. These putative Smaug1 mRNA targets remain to be 
identified. SREs may have loops up to seven nucleotides long, 
and  the  secondary  structure  that  surrounds  the  motifs  may   
affect their accessibility (Aviv et al., 2003, 2006; Green et al., 
2003; Johnson and Donaldson, 2006; Oberstrass et al., 2006; 
Foat and Stormo, 2009; Li et al., 2010; Ravindranathan et al., 
2010). Thus, the identification of mammalian Smaug1 targets 
will require intense investigation.
Materials and methods
Neuron culture, cell lines, and transfection
U2OS and HeLa cells were from the American Tissue Culture Collection 
and  grown  and  maintained  as  indicated.  Hippocampal  cultures  were 
prepared as described previously (Banker and Goslin, 1998). In brief, JCB • VOLUME 195 • NUMBER 7 • 2011   1154
in the antidigoxin antibody solution, or used after the biotinylated donkey 
anti–sheep. The secondary antibody for IF was always included in the 
streptavidin mix.
Images were acquired with PASCAL-LSM and LSM510 Meta con-
focal microscopes (Carl Zeiss), using C-Apochromat 40×/1.2 W Corr or 
63×/1.2 W Corr water immersion objectives for the LSM, and an EC 
“Plan-Neofluor” 40×/1.30 NA oil or Plan-Apochromat 63×/1.4 NA oil 
objective lenses for the LSM510 Meta. Images were acquired with LSM 
software (Carl Zeiss), and pixel intensity was always lower that 250, with 
255 being the level of saturation. Equipment adjustment was assessed by 
using 1 µm FocalCheck fluorescent microspheres (Invitrogen). No filters 
or gamma adjustment were used previous to the analysis of the object’s 
size, number, or intensity with the ImageJ software. The size and number 
of synapse puncta or Smaug granules was analyzed in maximum-inten-
sity z-stacks of 0.45-µm slices (63×). Values in Fig. 4 A; Fig. 5 (A, B, D, 
E and F), and Fig. 6 (A–C) are normalized to the number of synapses 
with S-foci under resting conditions, which were 62% for Fig. 4 A, 75% 
for Fig. 5 (A, B, and E) and Fig. 6 (A–C), and 67% for Fig. 5 D.
Magnifications in Fig. 1 (A and B), Fig. 2 (A and B), Fig. 3 (A, B, 
and D), Fig. 7 (A and B), Fig. 8 C, Fig. 9 (C and E), and Fig. 10 A were scaled 
using bilinear interpolation; and a Gaussian Blur, Sigma radius Max 2 filter, 
was applied to Fig. 4 A.
Hippocampus fractionation
Hand-dissected hippocampuses from adult mice were fractionated as de-
scribed previously (Phillips et al., 2001). In brief, a crude synaptosome 
preparation was extracted in 2% Triton X-100, pH 6, followed by 1% Triton   
X-100, pH 8.0, to obtain a fraction enriched in soluble presynaptic compo-
nents, and a fraction containing postsynaptic densities and insoluble pre-
synaptic proteins.
Western blotting and RT-PCR
Western  blotting  was  performed  by  standard  procedures  using  polyvi-
nylidene  fluoride  membranes  (Immobilon-P  polyvinylidene  difluoride; 
Millipore), LumiGlo (Cell Signaling Technology), and Hyperfilm (GE Health-
care). Primary antibodies were used as follows: anti-Smaug1 (Baez and 
Boccaccio,  2005),  diluted  1:5,000–1:10,000;  anti–-actin,  1:5,000–
1:10,0000  (Sigma-Aldrich);  anti-PSD95  (Millipore),  1:1,000;  anti–III- 
tubulin and anti-MAP2 (both from Sigma-Aldrich), 1:5,000; anti-Synapsin 
(Synaptic Systems), 1:5,000; and anti-Hedls. For semiquantitative analy-
sis, autoradiographs were scanned and signal intensity was assessed with 
the ImageJ software. RT-PCR was performed as described previously (Baez 
and Boccaccio, 2005) using the following primers for Smaug1: 5-TCGA-
CAGCAAAGAAATCGTG-3  and  5-AAGGCTGCAAAGTGTCTTGG-3; 
and the following primers for -actin: 5-TCTGTGTGGATTGGTGGCTCTA-3 
and 5-CTGCTTGCTGATCCACATCTG-3.
Statistics
The number of synapses, number cells, and/or dendritic lengths ana-
lyzed are indicated in each figure panel. Each experimental point in-
cludes duplicate or triplicate coverslips. P-values (*, P < 0.05; **, P < 
0.01; ***, P < 0.001) relative to control treatments according to two-
way ANOVA or the indicated test were determined using Infostat (Uni-
versidad Nacional de Córdoba) or Instat software (GraphPad Software, 
Inc.). Error bars represent standard error from independent experiments 
unless otherwise indicated.
Online supplemental material
Fig. S1 shows that a proportion of neuronal S-foci are in contact with PBs 
under resting conditions and that S-foci localize adjacent to SGs induced 
in  neurons  upon  exposure  to  oxidants.  Fig.  S2  shows  that  transfected 
Smaug1-ECFP or SAM-ECFP form foci in cell lines, which are distinct from 
SGs and in close contact with PBs. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201108159/DC1.
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90 mM KCl in isotonic Tyrode’s solution during 3 min were applied four 
times with 10 min intervals. TTX was applied during the resting intervals 
and after the stimulation phase.
FUNCAT
For labeling of newly synthesized proteins, HPG and AHA, both from 
Invitrogen, were used according to the manufacturer’s instructions. Before 
labeling, neurons were incubated during 30 min in methionine-free DME 
(Sigma-Aldrich) plus TTX, after an overnight treatment with TTX in NB. Then, 
HPG was added during 15 min. After a 5-min pulse with NMDA, without 
any tagged amino acid, and in the absence of methionine and TTX, cells 
were incubated with AHA during the indicated times. After fixation and 
permeabilization, cells were incubated with Alexa Fluor 594 azide (Alexa 
Fluor 594 carboxamido-(6-azidohexanyl) bis(triethylammonium salt); Invit-
rogen), which reacts with the azide group of AHA-bearing proteins, and 
then with Alexa Fluor 488 alkyne (Alexa Fluor 488 5-carboxamido-(propar-
gyl), bis(triethylammonium salt)), which reacts with the HPG azide group. 
Signal intensities were measured in dendrite fragments located at 50 µm 
or longer distances from the soma to minimize contribution from proteins 
delivered from the cell body (Dieterich et al., 2010).
IF, FISH, and image analysis
IF of cultured cells was performed after fixation, permeabilization, and 
blocking as usual (Thomas et al., 2005, 2009; Loschi et al., 2009). Pri-
mary antibodies were diluted as follows: anti-mammalian Smaug1, 1:300–
1:1,000 (Baez and Boccaccio, 2005); rabbit polyclonal anti-Dcp1 (a gift 
from J.L. Andersen, University of California, San Diego, La Jolla, CA), 
1:100; monoclonal IgG2a anti Dcp1a (Abnova Corporation), 1:1,000; 
polyclonal rabbit anti-Hedls and anti Rck/p54 (Bethyl Laboratories, Inc.), 
1:500; monoclonal IgG2a anti-PSD95 (Millipore), 1:100; IgG2b anti-tubulin 
III and IgG1 anti-MAP2 (both from Sigma-Aldrich), 1:500; IgG1 anti- 
Synapsin (Synaptic Systems), 1:100; polyclonal anti-Arc (catalog no. 156 
003; Synaptic Systems), 1:500; polyclonal anti-Staufen (Thomas et al., 2005), 
1:400; IgG2b anti-FMRP, clone 7G1-1 (Developmental Studies Hybridoma 
Bank), 1:50; IgG1 anti-TIAR (BD), 1:100; and monoclonal anti-CaMKII 
(Abcam), 1:500. Secondary antibodies coupled to Alexa Fluor 488, Alexa 
Fluor 555, or Alexa Fluor 666, used at 1:500–1:1,000, were obtained 
from Invitrogen. Secondary antibodies coupled to Cy2, Cy3, or Cy5, 
used at 1:300–1:500, were from Jackson ImmunoResearch Laboratories, 
Inc. Phalloidin conjugated to FITC (Sigma-Aldrich) or to Alexa Fluor 546 
(Invitrogen) was used.
Brain sections, provided by A. Schinder and A.J. Ramos (University 
of Buenos Aires) were stained in a free-floating system, as described previ-
ously (Aviles-Reyes et al., 2010). In brief, after antigen retrieval by treat-
ment at 95°C for 5 min, vibratome sections were blocked in 10% normal 
donkey serum in PBS containing 0.3% Triton X-100, and incubated over-
night with anti-Smaug (1:100), anti-synapsin (1:200), or anti-tubulin III 
(1:200)  at  4°C.  Donkey  secondary  antibodies  anti–rabbit,  anti–mouse 
IgG1, or IgG2b (Jackson) were used at 1:250. Sections were mounted in 
PVA-Dabco (Sigma-Aldrich).
For  FISH,  a  pBlueScript  plasmid  (Agilent  Technologies)  contain-
ing 240 bp from the coding region and contiguous 3,280 bp from the 
3 UTR of rat CaMKII was provided by S. Kindler (University Medical 
Center Hamburg-Eppendorf, Hamburg, Germany). Sense and antisense   
digoxigenin-RNA probes were synthesized according to the manufacturer’s 
instructions (Roche), and combined FISH-IF was performed as described 
previously (Thomas et al., 2005). In brief, cells were fixed in 4% parafor-
maldehyde, 4% sucrose, and 2 mM MgCl2 in PBS for 15 min at 37°C; 
washed three times in 4% sucrose and PBS; and UV cross-linked (CL pro-
gram, GS Gene Linker; Bio-Rad Laboratories, Inc.). Cells were then treated 
with 0.3% Triton X-100 in PBS for 5 min, washed with 2 mM MgCl2 in 
PBS, and dried completely. After prehybridization in 50% formamide, 5× 
SSC, 0.2% SDS, 50 mg/ml heparin, 250 mg/ml salmon sperm DNA, and 
250 mg/ml yeast tRNA (all from Sigma-Aldrich), overnight hybridization   
was performed at 55°C in the same solution supplemented with 100 mg/ml   
heparin and 100 ng/ml digoxigenin-riboprobe. After washing twice 
at room temperature with 1× SSC, 0.1% SDS, and twice at 50°C with 
0.2× SSC, 0.1% SDS, blocking was performed with 1% blocking reagent 
(Boehringer Ingelheim) in PBS. The probe signal was amplified in one or 
two steps with the following antibodies: biotinylated mouse antidigoxin 
(Sigma-Aldrich) or sheep antidigoxigenin (Boehringer Ingelheim) followed 
by  biotinylated  donkey  anti–sheep  (Jackson  ImmunoResearch  Laborato-
ries, Inc.). Then, anti–mouse A488 or streptavidin coupled to Cy2 (Jackson 
ImmunoResearch Laboratories, Inc.) was used. All incubations were per-
formed for 2 h at room temperature and were followed by three washes in 
PBS with Tween 20 (PBST). The first antibody for the IF was either included 1155 Smaug1 mRNA-silencing foci at the synapse • Baez et al.
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